Is cough a symptom of Nipah virus infection, particularly in older adults with underlying medical conditions such as chronic obstructive pulmonary disease (COPD) or heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Cough a Symptom of Nipah Virus Infection?

Yes, cough is a common and prominent symptom of Nipah virus infection, occurring in the majority of patients and representing one of the key clinical features of this severe zoonotic disease. 1

Clinical Presentation of Nipah Virus

Cough ranks among the most frequently reported symptoms in Nipah virus infection, appearing alongside fever, altered mental status, headache, respiratory difficulty, vomiting, and convulsions. 1 In the Bangladesh outbreaks during 2001-2004, cough was documented as one of the most common presenting signs in patients with confirmed Nipah virus infection. 1

Respiratory Manifestations

  • Respiratory involvement is substantial in Nipah virus infection, with clinical and radiographic features of acute respiratory distress syndrome (ARDS) identified during documented outbreaks. 1
  • The clinical presentation ranges from asymptomatic infection to fatal encephalitis, with severe respiratory disease being a hallmark feature. 2
  • Nipah virus causes severe neurological AND respiratory disease, distinguishing it from purely neurological infections. 3, 4

High-Risk Populations

Older adults with underlying conditions like COPD or heart failure face particularly elevated risk when infected with Nipah virus, as the severe respiratory component can rapidly progress to respiratory failure. 1 Patients who died from Nipah virus infection were significantly more likely to have difficulty breathing compared to survivors. 1

Disease Severity and Progression

  • The mortality rate for Nipah virus infection is extremely high at 73% based on Bangladesh outbreak data. 1
  • Among fatal cases, death occurred a median of 6 days (range 2-36 days) after illness onset. 1
  • Patients who died were more likely to present with fever >37.8°C, altered mental status, difficulty breathing, and abnormal plantar reflexes. 1

Geographic and Transmission Considerations

  • Outbreaks have occurred in Malaysia, Singapore, Bangladesh, India, and the Philippines. 3, 2
  • Human-to-human transmission is common in Bangladesh, occurring through close contact with clinically-unwell patients or their infectious secretions. 5
  • The median incubation period is 9 days (range 6-11 days) among patients with well-defined exposure. 1

Clinical Pitfalls

The respiratory symptoms of Nipah virus, including cough, can initially mimic common respiratory infections, potentially delaying diagnosis and implementation of critical infection control measures. 4 Rapid diagnosis is essential to contain outbreaks, as the virus is highly infectious and spreads through infected animals or people. 4

There are currently no effective therapeutics available, making supportive care and prevention the mainstays of management. 2 This underscores the critical importance of early recognition based on clinical features like cough in endemic areas or following potential exposure.

References

Research

Clinical presentation of nipah virus infection in Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008

Research

Nipah Virus Infection.

Journal of clinical microbiology, 2018

Research

Nipah virus infection: A review.

Epidemiology and infection, 2019

Research

Nipah virus: transmission of a zoonotic paramyxovirus.

Current opinion in virology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.